🇺🇸 FDA
Patent

US 7364719

Vasoregulating compounds and methods of their use

granted A61KA61K31/137A61K38/22

Quick answer

US patent 7364719 (Vasoregulating compounds and methods of their use) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Apr 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/137, A61K38/22, A61P, A61P9/12